Higher bleeding risk even with brief use of NSAID or aspirin, when on anticoagulation
23-4-2014 • Davidson BL et al., JAMA Intern Med. 2014
A clinically important increase in bleedings was observed in patients treated for VTE, who are simultaneously using anticoagulation and NSAIDs or aspirin.
Metabolic health in obese affects risk of diabetes, but not of incident CVD
20-4-2014 • Hinnouho GM et al., Eur Heart J. 2014
Metabolically healthy obese individuals have a lower risk of type 2 diabetes than the metabolically unhealthy obese, but the metabolically healthy remain at high risk for incident CVD.
Women with heart failure benefit from exercise training
17-4-2014 • Piña IL et al. JACC Heart Fail. 2014
In HF-ACTION, an exercise program plus optimal medical therapy (OMT) was associated with a lower risk of all-cause mortality and hospitalisation than OMT alone, in women, but not men with HF.
Better prognosis for overweight and obese patients with CVD (the "obesity paradox")
10-4-2014 • Lavie CJ, et al. JACC 2014
Overweight and obese patients with CV diseases have a better prognosis than do their leaner counterparts, largely in patients with low fitness.
Prediction of incident CVD is hardly improved by addition of HbA1c to conventional risk factors in non-diabetics
31-3-2014 • The Emerging Risk Factors Collaboration
In adults without a known history of diabetes of CVD, adding information on glycaemic measures does not yield clinically relevant improvement of CVD risk assessment.
Diabetes during pregnancy is a risk factor for subclinical atherosclerosis later in life
20-3-2014 • Gunderson EP et al., J Am Heart Assoc. 2014
Women with a history of GDM had greater carotid artery IMT, already before the onset of diabetes and the metabolic syndrome, irrespective of pre-pregnancy obesity, race, parity and age.
Webcast • Amsterdam
Stroke prevention in atrial fibrillation
Four European Primary Care experts, prof. Richard Hobbs, prof. David Fitzmaurice, Clare Taylor MD and Frans Rutten MD, summarise a fascinating discussion at the stroke prevention in atrial fibrillation expert meeting.
News • 20-4-2014
Polypills should play a larger role in secondary prevention of CV disease
Two authors advocate the inclusion of fixed-dose combination therapy in the WHO Model List of Essential Medicins, to improve its access and use, to avoid premature death from CVD.
ACE inhibitors and ARBs differentially affect CV morbidity and mortality in diabetics
15-4-2014 • Cheng J et al., JAMA Intern Med. 2014
Meta-analysis shows that ACEIs and ARBs differentially influence the risk of all-cause mortality, CV deaths and CV events in patients with DM. ACEIs reduce the risk, while ARBs do not.
Control of atherosclerotic plaques improved during last decade
8-4-2014 • Van Lammeren GW et al. Circulation 2014
Over time, less unstable plaques and more frequently stable plaques were found in study of University Medical Center Utrecht.
News • 26-3-2014
Joint British Societies publish new guidelines for CVD prevention: JBS3
The Joint British Societies have published new consensus recommendations for the prevention of cardiovascular disease, with a focus on lifetime CV risk.
Single-patient n-of-1 trials can improve assessment of statin-related myalgia
19-3-2014 • Joy TR et al., Ann Intern Med. 2014
This proof-of-concept study supports the use of n-of-1 trials in motivated patients to identify truly statin-caused myalgia. This study found no clinically significant difference in myalgia between statins and placebo.
XIIIth International Primary Care Diabetes Europe Conference
May 23-24, 2014, Barcelona
EPCCS Annual meeting 2014
September 18-19, 2014, Brussels, Belgium
All upcoming meetings...
Meeting reports & resources
Report of 6th Annual EPCCS meeting held in London
Report of 5th Annual EPCCS meeting held in Athens
Report of 4th Annual EPCCS meeting held in Berlin
Report of 3rd Annual EPCCS meeting held in Lisbon
All meeting reports...